Fuji Pharma – pharmaceutical daily

March 21, 2019 Off

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

December 18, 2018 Off

Japan-based Fuji Pharma buys $50 million worth 4.2% stake in Alvotech

By Dino Mustafić

Japan-based Fuji Pharma has acquired a 4.2% stake in the biopharmaceutical company Alvotech for around $50 million.

June 28, 2017 Off

Mitra, Fuji Pharma ink women’s health product deal in Japan

By Dino Mustafić

An exclusive License and Supply Agreement (LSA) has been signed between Fuji Pharma, the leader in women’s health in Japan, and Mithra, a Euronext -listed company specialized in women’s health, for the commercialization of Donesta in Japan and ASEAN territories.